Results 41 to 50 of about 34,974 (164)

Corneal Endothelial Cell Loss in Glaucoma and Glaucoma Surgery and the Utility of Management with Descemet Membrane Endothelial Keratoplasty (DMEK)

open access: yesJournal of Ophthalmology, Volume 2022, Issue 1, 2022., 2022
The corneal endothelium has a crucial role in maintaining a clear and healthy cornea. Corneal endothelial cell loss occurs naturally with age; however, a diagnosis of glaucoma and surgical intervention for glaucoma can exacerbate a decline in cell number and impairment in morphology. In glaucoma, the mechanisms for this are not well understood and this
Neeru A Vallabh   +8 more
wiley   +1 more source

Mispositioned Hydrus Microstents: A Case Series Imaged with NIDEK GS‐1 Gonioscope

open access: yesJournal of Ophthalmology, Volume 2022, Issue 1, 2022., 2022
Introduction. The Hydrus microstent has become a common procedure in glaucoma surgery intended to improve outcomes of cataract surgery to lower intraocular pressure. Despite proper placement, this device can subsequently be noted to not be in the proper position. In this case series, we report mispositioned Hydrus microstents in five different patients
Daniel Laroche   +5 more
wiley   +1 more source

Outcomes of Anterior Chamber, Sulcus, and Pars Plana Glaucoma Drainage Device Placement in Glaucoma Patients

open access: yesJournal of Ophthalmology, Volume 2022, Issue 1, 2022., 2022
Purpose. To assess outcomes of anterior chamber (AC), sulcus, and pars plana (PP) glaucoma drainage device (GDD) placement in glaucoma patients. Patients and Methods. Retrospective evaluation of glaucoma patients who underwent GDD insertion in the AC, sulcus, or PP at Massachusetts Eye and Ear between November 2016 and May 2021.
Sandy Samuel   +8 more
wiley   +1 more source

Prevalence of zonulopathy in primary angle closure disease

open access: yesClinical &Experimental Ophthalmology, Volume 49, Issue 9, Page 1018-1026, December 2021., 2021
Abstract Background To determine the prevalence of zonulopathy in a large cohort of eyes with primary angle closure disease (PACD) that underwent cataract surgery. Methods Retrospective consecutive case series of PACD eyes (including primary angle closure suspect, primary angle closure, and primary angle closure glaucoma) that underwent ...
Ali Salimi   +5 more
wiley   +1 more source

XEN® Gel Stent compared to PRESERFLO™ MicroShunt implantation for primary open‐angle glaucoma: two‐year results

open access: yesActa Ophthalmologica, Volume 99, Issue 3, Page e433-e440, May 2021., 2021
Abstract Purpose To evaluate the long‐term efficacy and safety of two minimally invasive glaucoma surgery implants with a subconjunctival drainage approach: the XEN45 Gel Stent® (Xen) implant and the PRESERFLO™ MicroShunt (MicroShunt). Methods Retrospective comparative case series of primary open‐angle glaucoma (POAG) patients with at least 6 months of
Lotte M.J. Scheres   +7 more
wiley   +1 more source

XEN Glaucoma Implant for the Management of Operated Uncontrolled Glaucoma: Results and Complications during a Long‐Term Follow‐Up

open access: yesJournal of Ophthalmology, Volume 2021, Issue 1, 2021., 2021
This study aimed to analyze the surgical and refractive outcomes of XEN glaucoma implant (Allergan, an Abbvie company, Irvine, CA, USA), a minimally invasive surgical device for the treatment of operated uncontrolled glaucoma. Eyes that received XEN Gel Stent placement from December 2014 to October 2019 were retrospectively investigated.
Katarzyna Lewczuk   +7 more
wiley   +1 more source

Twelve-Month Outcomes of iStent Infinite in Severe Open-Angle Glaucoma Compared with iStent Inject W in Mild-to-Moderate Disease. [PDF]

open access: yesJ Clin Med
Background/Objectives: The efficacy of two-stent implantation with iStent inject W is well established for mild-to-moderate open-angle glaucoma (OAG), whereas evidence for three-stent implantation with iStent infinite in severe OAG remains limited. We compared 12-month outcomes of a severity-based surgical strategy, using two stents in mild-to-moderate
Han S, Kim SW.
europepmc   +4 more sources

Comparison of Surgical Times for Gonio Lenses and Viewing Systems in iStent Inject<sup>®</sup> W Surgery. [PDF]

open access: yesJ Clin Med
Background/Objectives: The aim of the study was to investigate the difference in operative times for iStent inject® W (iStent) implantation based on variations in the gonio lens and with use of a surgical microscope or the NGENUITY® 1.5 (Alcon ...
Fujii T   +3 more
europepmc   +2 more sources

Resultados longitudinais comparativos de mundo real do iStent inject® versus iStent inject® W no glaucoma de ângulo aberto [PDF]

open access: yesRevista Brasileira de Oftalmologia
RESUMO Objetivo: Comparar a eficácia e a segurança do iStent inject® e do iStent inject® W em pacientes com glaucoma primário de ângulo aberto submetidos a implante isolado ou combinado com facoemulsificação. Métodos: Estudo retrospectivo, longitudinal,
Daniel Augusto Guedes Moraes   +5 more
doaj   +2 more sources

Five-Year Outcomes of iStent inject Implantation With or Without Phacoemulsification in Eyes with Open-Angle Glaucoma. [PDF]

open access: yesOphthalmol Ther
Introduction Minimally invasive glaucoma surgery (MIGS) has become more widespread in open-angle glaucoma (OAG) management. Broad evidence has shown a greater decrease in mean intraocular pressure (IOP) when cataract surgery is combined with MIGS ...
Guedes RAP   +4 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy